Azenta, Inc. (AZTA) vs Celldex Therapeutics, Inc. (CLDX)
A side-by-side comparison of Azenta, Inc. and Celldex Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AZTA
Azenta, Inc.
$40.90HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
CLDX
Celldex Therapeutics, Inc.
$31.42HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — AZTA vs CLDX
growth of $100 · dividends reinvested · last 10yAZTA +237.6% (+12.9%/yr)CLDX -36.8% (-4.5%/yr)AZTA compounded faster over this window
Log scale — wide-divergence pair
AZTA CLDX
AZTA vs CLDX: by the numbers
- •CLDX is the larger company ($2.09B vs $1.89B market cap).
- •Both run net losses; AZTA's is the smaller (-20.02% vs -268385.71% net margin).
- •AZTA grew revenue faster over the past five years (4.82% vs -58.05% CAGR).
Metrics side by side
Valuation
| Metric | AZTA | CLDX |
|---|---|---|
| Forward P/E | 82.34 | N/A |
| P/S ratio | 3.07 | 18666.41 |
| P/B ratio | 1.25 | 2.93 |
| EV / EBITDA | 51.09 | N/A |
| FCF yield | 0.52% | N/A |
Profitability
| Metric | AZTA | CLDX |
|---|---|---|
| Gross margin | 44.05% | 100.00% |
| Operating margin | -3.49% | -19160.00% |
| Net margin | -20.02% | -268385.71% |
| ROE | -8.14% | -42.07% |
| ROIC | -1.33% | -45.19% |
Growth (annualized)
| Metric | AZTA | CLDX |
|---|---|---|
| Revenue CAGR (5Y) | 4.82% | -58.05% |
| Total return CAGR (5Y) | -15.91% | -10.28% |
Frequently asked
- Which has grown faster, AZTA or CLDX?
- Over the past five years, AZTA grew revenue faster — AZTA at a 4.82% CAGR versus CLDX at -58.05%.
- How have AZTA and CLDX total returns compared?
- Over the past 10 years, AZTA delivered 12.81% and CLDX delivered -6.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.